0001437749-20-019131.txt : 20200901 0001437749-20-019131.hdr.sgml : 20200901 20200901170847 ACCESSION NUMBER: 0001437749-20-019131 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200831 FILED AS OF DATE: 20200901 DATE AS OF CHANGE: 20200901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hanna John Walter JR CENTRAL INDEX KEY: 0001781127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 201155017 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 rdgdoc.xml FORM 4 X0306 4 2020-08-31 0001384101 VERACYTE, INC. VCYT 0001781127 Hanna John Walter JR 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 Chief Commercial Officer Common Stock 2020-08-31 4 M 0 53 4 A 74687 D Common Stock 2020-08-31 4 M 0 9000 14.34 A 83687 D Common Stock 2020-08-31 4 M 0 8835 8.86 A 92522 D Common Stock 2020-08-31 4 M 0 19336 6.45 A 111858 D Common Stock 2020-08-31 4 M 0 9375 9.05 A 121233 D Common Stock 2020-08-31 4 M 0 9844 5.98 A 131077 D Common Stock 2020-08-31 4 S 0 55970 33.3674 D 75107 D Common Stock 2020-08-31 4 S 0 473 33.7762 D 74634 D Stock Option (right to buy) 4 2020-08-31 4 M 0 53 0 D 2023-02-04 Common Stock 53 0 D Stock Option (right to buy) 14.34 2020-08-31 4 M 0 9000 0 D 2024-02-18 Common Stock 9000 0 D Stock Option (right to buy) 8.86 2020-08-31 4 M 0 8835 0 D 2025-03-01 Common Stock 8835 2 D Stock Option (right to buy) 6.45 2020-08-31 4 M 0 19336 0 D 2026-02-28 Common Stock 19336 2 D Stock Option (right to buy) 9.05 2020-08-31 4 M 0 9375 0 D 2027-03-02 Common Stock 9375 10417 D Stock Option (right to buy) 5.98 2020-08-31 4 M 0 9844 0 D 2028-03-01 Common Stock 9844 24063 D The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. Represents weighted average sales price. Sale prices for the transactions range from $32.72 to $33.71. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Represents weighted average sales price. Sale prices for the transactions range from $33.77 to $33.81. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. The option is fully vested. The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. /s/ Keith Kennedy, as Attorney-in-fact 2020-09-01